HOX and PBX gene dysregulation as a therapeutic target in glioblastoma multiforme. Arunachalam E, Rogers W, Simpson GR, Moller-Levet C, et al. BMC Cancer 2022;22:400.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Arunachalam E, Rogers W, Simpson GR, Moller-Levet C, et al. HOX and PBX gene dysregulation as a therapeutic target in glioblastoma multiforme. BMC Cancer 2022;22:400.
PMID: 35418059